 |
|
 |
| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5830888 |
Macrocyclic retroviral protease inhibitors |
Nov. 3, 1998 |
| 5824346 |
Combination therapy for advanced cancer |
Oct. 20, 1998 |
| 5814643 |
Sulfonamide fibrinogen receptor antagonists |
Sep. 29, 1998 |
| 5807850 |
Therapeutic agent for osteoporosis and triazepine compound |
Sep. 15, 1998 |
| 5801023 |
Antiparasitic pyrrolobenzoxazine compounds |
Sep. 1, 1998 |
| 5801181 |
Amino alcohol substituted cyclic compounds |
Sep. 1, 1998 |
| 5798390 |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
Aug. 25, 1998 |
| 5795574 |
Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it |
Aug. 18, 1998 |
| 5789413 |
Alkylated styrenes as prodrugs to COX-2 inhibitors |
Aug. 4, 1998 |
| 5786344 |
Camptothecin drug combinations and methods with reduced side effects |
Jul. 28, 1998 |
| 5786349 |
Method for treating chlamydia infectious diseases by rifamycin derivative |
Jul. 28, 1998 |
| 5786350 |
36-derivatives of rifamycins and their use as antimicrobial agents |
Jul. 28, 1998 |
| 5780461 |
Therapeutic treatment of cancer with Protein Kinase C inhibitors |
Jul. 14, 1998 |
| 5780462 |
Water soluble rapamycin esters |
Jul. 14, 1998 |
| 5776891 |
Compositions for reducing multidrug resistance |
Jul. 7, 1998 |
| 5773435 |
Prodrugs for .beta.-lactamase and uses thereof |
Jun. 30, 1998 |
| 5770590 |
Cyclic compounds, their prudiction and use |
Jun. 23, 1998 |
| 5767162 |
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
Jun. 16, 1998 |
| 5767274 |
Prenyl transferase inhibitors |
Jun. 16, 1998 |
| 5763445 |
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
Jun. 9, 1998 |
| 5763460 |
N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-htia receptor antagonists |
Jun. 9, 1998 |
| 5756492 |
Graft survival prolongation with porphyrins |
May. 26, 1998 |
| 5756522 |
Triazole derivatives and uses thereof |
May. 26, 1998 |
| 5753677 |
Benzoheterocyclic compounds |
May. 19, 1998 |
| 5750518 |
Heterocyclic compounds |
May. 12, 1998 |
| 5747069 |
Percutaneously absorbable preparation |
May. 5, 1998 |
| 5747481 |
Heterocyclic compounds |
May. 5, 1998 |
| 5744472 |
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
Apr. 28, 1998 |
| 5741788 |
Heterocyclic compounds and their preparation and use |
Apr. 21, 1998 |
| 5739022 |
Copper(II) nuclease compounds, compositions, and kits |
Apr. 14, 1998 |
| 5733867 |
1, 5-benzodiazepine derivatives |
Mar. 31, 1998 |
| 5733924 |
DC 107 derivatives and treatment methods |
Mar. 31, 1998 |
| 5731303 |
Transdermal and trans-membrane delivery compositions |
Mar. 24, 1998 |
| 5731304 |
Potentiation of temozolomide in human tumour cells |
Mar. 24, 1998 |
| 5731305 |
Anti-hypertension compositions of secondary amine-nitric oxide adducts and use thereof |
Mar. 24, 1998 |
| 5731320 |
Macrocyclic amide and urea immunomodulators |
Mar. 24, 1998 |
| 5728687 |
Antitumour compositions containing taxane derivatives |
Mar. 17, 1998 |
| 5723456 |
Therapeutic treatment for cardiovascular diseases |
Mar. 3, 1998 |
| 5723457 |
Acylmercaptoalkanoylamino and mercaptoalkanoylamino benzazepines |
Mar. 3, 1998 |
| 5721253 |
Fibrinogen receptor antagonists |
Feb. 24, 1998 |
| 5719156 |
Piperazino derivatives as neurokinin antagonists |
Feb. 17, 1998 |
| 5719186 |
Amide derivatives and their therapeutic use |
Feb. 17, 1998 |
| 5710145 |
Protein kinase C inhibitor |
Jan. 20, 1998 |
| 5707867 |
Antiviral compounds |
Jan. 13, 1998 |
| 5707985 |
Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators |
Jan. 13, 1998 |
| 5707989 |
Pyrimido[5,4-D]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
Jan. 13, 1998 |
| 5705497 |
3-alkoxycarbonyl-thiadiazinones |
Jan. 6, 1998 |
| 5705501 |
Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease |
Jan. 6, 1998 |
| 5705509 |
Tricyclic heterocyclic compounds as 5-HT.sub.4 receptor antagonists |
Jan. 6, 1998 |
| 5703065 |
Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds |
Dec. 30, 1997 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
